These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
500 related items for PubMed ID: 22019005
1. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin. Swindle JP, Potash J, Kulakodlu M, Kuznik A, Buikema A. Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005 [Abstract] [Full Text] [Related]
7. Comparison of cardiovascular event rates in patients without cardiovascular disease in whom atorvastatin or simvastatin was newly initiated. Jacobson TA, Wertz DA, Hoy T, Kuznik A, Grochulski D, Cziraky M. Mayo Clin Proc; 2008 Dec; 83(12):1316-25. PubMed ID: 19046550 [Abstract] [Full Text] [Related]
9. Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol. Aronow HD, Hess G, Hill J, Kuznik A, Liu LZ. Am J Ther; 2010 Dec; 17(2):167-75. PubMed ID: 19770794 [Abstract] [Full Text] [Related]
10. Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy. Rublee DA, Chen SY, Mardekian J, Wu N, Rao P, Boulanger L. Am J Ther; 2012 Jan; 19(1):24-32. PubMed ID: 20838204 [Abstract] [Full Text] [Related]
12. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. Ohsfeldt RL, Gandhi SK, Fox KM, Stacy TA, McKenney JM. Am J Manag Care; 2006 Nov; 12(15 Suppl):S412-23. PubMed ID: 17112329 [Abstract] [Full Text] [Related]
13. Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatin. Jacobson TA, Wertz DA, Kuznik A, Cziraky M. Curr Med Res Opin; 2013 Jul; 29(7):773-81. PubMed ID: 23647370 [Abstract] [Full Text] [Related]
14. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001 [Abstract] [Full Text] [Related]
15. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study. Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW. Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326 [Abstract] [Full Text] [Related]
16. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting. Fox KM, Gandhi SK, Ohsfeldt RL, Davidson MH. Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777 [Abstract] [Full Text] [Related]
17. Differences between statins on clinical endpoints: a population-based cohort study. Dieleman JP, van Wyk JT, van Wijk MA, van Herpen G, Straus SM, Dunselman H, Sturkenboom MC. Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665 [Abstract] [Full Text] [Related]
19. Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. Foody JM, Joyce AT, Rudolph AE, Liu LZ, Benner JS. Curr Med Res Opin; 2008 Jul; 24(7):1987-2000. PubMed ID: 18554430 [Abstract] [Full Text] [Related]